Module

Diagnosis and Treatment Options for Chronic Hepatitis B

Source: Diagnosis, Treatment, and Chronic Care Options for Hepatitis B

Diagnosis and Treatment Options for Chronic Hepatitis B


CME Program Director: Patrick J. Lynch, MD

Program Director: Eugene R. Schiff, MD, MACP, FRCP, MACG

Faculty:

Emmet B. Keeffe, MD, MACP
  • Emmet B. Keeffe, MD, MACP

CME CREDIT INFORMATION

Release Date: 07/18/05

Expiration Date: 07/17/06


Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.2 Nursing CE credits

Pharmacists: 1.0 contact hour (0.1 CEUs)

Status: Please log in to view status

Begin the Module

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Review the current and emerging treatment choices in chronic hepatitis B, including advantages and disadvantages of each treatment option.

  • Discuss the different prophylactic and treatment approaches for various individual HBV- infected populations, including HBeAg(+) vs (-), coinfected patients, pregnant women, and immunocompromised individuals.

  • Describe the natural history of chronic hepatitis B virus infection, and factors involved in proper diagnosis.


Content includes:

  • Phases of Natural History in Chronic HBV Infection
  • Cirrhosis and Hepatocellular Carcinoma
  • Diagnosis
  • Overview of HBV Treatment
  • Treatment of HBeAg-Positive Chronic Hepatitis B
  • Interferon Alfa
  • Lamivudine
  • Adefovir Dipivoxil
  • Entecavir
  • Peginterferon Alfa
  • Treatment of HBeAg-Negative Chronic Hepatitis B
  • Cirrhosis in Chronic Hepatitis B Infection
  • Coinfection with HCV in Chronic Hepatitis B Infection
  • HBV Treatment During Chemotherapy and Following Liver Transplant
  • Coinfection with HDV in Chronic Hepatitis B Infection
  • Pregnancy and Perinatal Transmission of HBV
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.

Pharmacist and nursing credit provided through the cosponsorship of Medical Education Collaborative and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.